Ertumaxomab
Overview
Ertumaxomab (marketed under the brand name Rexomun®) is a rat-murine hybrid monoclonal antibody which it’s used to treat some cancers.
Template:Rat-murinehybridmonoclonals
Template:WH
Template:WS
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
